Goodrx Holdings Inc
NASDAQ:GDRX

Watchlist Manager
Goodrx Holdings Inc Logo
Goodrx Holdings Inc
NASDAQ:GDRX
Watchlist
Price: 2.85 USD -1.72% Market Closed
Market Cap: 967.4m USD

Goodrx Holdings Inc
Investor Relations

GoodRx Holdings Inc., established at the intersection of healthcare and technology, has carved a niche in the American pharmaceutical industry by addressing one of its most notorious challenges: the high cost of prescription medications. Originally founded in 2011, GoodRx aims to ease the financial burden of medication costs for consumers by providing a platform that aggregates drug pricing information from pharmacies across the United States. By doing so, it empowers users to compare prices, identify potential savings, and subsequently make informed decisions about their medication purchases. At its core, GoodRx operates as a digital intermediary; its app and website seamlessly connect consumers with discounted prescription offers through partnerships with pharmacy benefit managers (PBMs) and retail pharmacies.

The company's revenue model is primarily built on a commission and advertising framework. When users select a coupon from GoodRx and purchase at a pharmacy, the company receives a fee from its pharmacy partners or PBMs. Additionally, GoodRx leverages its vast user base, which is largely driven by organic traffic resulting from the essential nature of its service, to generate advertising revenues from pharmaceutical companies and other health-related entities eager to reach consumers actively seeking medication solutions. By continually expanding its services, such as telehealth offerings and a subscription model called GoodRx Gold, the company seeks to deepen its integration into the consumer healthcare experience while maintaining its core mission of providing accessible and affordable medication options.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2025
Call Date
Nov 5, 2025
AI Summary
Q3 2025

Revenue: Q3 revenue was $196 million, up $1 million year-over-year, but prescription transaction revenue was down 9% due to Rite Aid closures and lower volume in an integrated savings program.

Manufacturer Solutions Strength: Manufacturer Solutions revenue grew 54% year-over-year to $43.4 million, driven by new and expanded partnerships, and is projected to grow about 35% for the full year.

Profitability: Adjusted EBITDA rose 2% to $66.3 million with margin improvement of 50 basis points to 33.8%.

Guidance Unchanged: Full-year revenue guidance remains at or above $792 million, and adjusted EBITDA guidance is unchanged at approximately 2% to 6% growth, with Q4 revenue expected to decline sequentially.

Strategic Partnerships: Expanded direct-to-consumer cash programs with major pharma (Novo Nordisk, Amgen) and launched new pharmacy solutions like RxSmartSaver at Kroger nationwide.

Macro Tailwinds Expected: Management sees 2026 benefiting from increased uninsured rates and higher out-of-pocket costs, likely boosting cash prescription volumes and supporting long-term growth.

Marketing & Brand: New brand campaign increased unaided awareness and search volume, reinforcing GoodRx as a trusted name in prescription savings.

Key Financials
Revenue
$196 million
Manufacturer Solutions Revenue
$43.4 million
Adjusted EBITDA
$66.3 million
Adjusted EBITDA Margin
33.8%
Cash on Hand
$273.5 million
Share Repurchases
13.4 million shares at an average price of $4.61 per share, totaling $61.6 million
Share Repurchase Program Remaining Capacity
$81.4 million remaining under $450 million program
Earnings Call Recording
Other Earnings Calls

Management

Mr. Trevor Bezdek
Co-founder & Chairman of the Board
No Bio Available
Mr. Scott W. Wagner
Interim CEO & Principal Operating Officer
No Bio Available
Mr. Douglas Joseph Hirsch
Co-founder, Chief Mission Officer & Director
No Bio Available
Mr. Karsten Ian Voermann
Chief Financial Officer
No Bio Available
Mr. Romin Nabiey
Chief Accounting Officer
No Bio Available
Mr. Bansi Nagji
President of Healthcare
No Bio Available
Mr. Mike Walsh
President & Executive VP of Prescription Marketplace
No Bio Available
Mr. Nitin Shingate
Chief Technology Officer
No Bio Available
Ms. Aubrey Reynolds
Director of Investor Relations
No Bio Available
Ms. Gracye Cheng
General Counsel & Secretary
No Bio Available

Contacts

Address
CALIFORNIA
Santa Monica
2701 Olympic Boulevard, Suite 990
Contacts
+18552682822.0
investors.goodrx.com